• Vaxil Locations
  • Contact Us
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • 2025 Shareholder Meeting Material

Category Archives: Annnouncements

27 Jan
Annnouncements

VAXIL PROVIDES UPDATE ON USAMRIID, ORAL EXPERIMENT AND OTHER GENERAL BUSINESS MATTERS

… Read the rest
Posted on January 27, 2021 by Gadi Levin
02 Jan
Annnouncements

VAXIL’S ANNUAL AND SPECIAL SHAREHOLDERS MEETING AND UPDATE ON EXERCISE OF WARRANTS

… Read the rest
Posted on January 2, 2021 by Gadi Levin
31 Dec
Annnouncements

VAXIL PROVIDES UPDATE ON USAMRIID AND ORAL EXPERIMENTS

… Read the rest
Posted on December 31, 2020 by Gadi Levin
22 Dec
Annnouncements

VAXIL RETAINS INVESTOR ENGAGEMENT AND MARKETING FIRM

… Read the rest
Posted on December 22, 2020December 22, 2020 by Gadi Levin
10 Dec
Annnouncements

VAXIL ANNOUNCES CLOSE OF SECOND AND FINAL TRANCHE OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT FOR GROSS PROCEEDS OF $264,100 – TOTAL GROSS PROCEEDS REACH $806,958

… Read the rest
Posted on December 10, 2020 by Gadi Levin
Older posts
Newer posts

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, Weizmann Science Park, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Presentations
  • Public Filings
  • News and Updates
  • In the Media
  • Video
  • Scientific Publications
Copyright 2025 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • 2025 Shareholder Meeting Material
  • Vaxil Locations
  • Contact Us
  • Subscribe